Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1060 | Male Reproduction | ICEECE2012

Testosterone replacement therapy: A comparison of testosterone mixed esters, extended release testosterone implants and testosterone undecanoate depot

Conaglen Helen M. , Yarndley Tania , Kamp Jozef , Paul Ryan G , Nirmalaraj Kingsley , Elston Marianne S , Conaglen John V

Introduction: Male hypogonadism is one of the most common endocrine disorders affecting 5.6% of men aged between 30–79 years. Testosterone deficiency (TD) is an independent risk factor for multiple cardiovascular risk factors including obesity, diabetes mellitus, hypertension, dyslipidaemia and endothelial dysfunction. The aims of testosterone replacement treatment (TRT) in hypogonadism are to improve or ameliorate the clinical features and to restore the serum T to physi...